Retatrutide significantly reduced body weight (mean difference [MD]: 14.33%), body mass index (MD: 5.38), waist circumference (MD: 10.51 cm), fasting plasma glucose (MD: 23.51 mg/dL), hemoglobin A1c (MD: 0.91%), and systolic and diastolic blood pressure (MD: 9.88 mm Hg and 3.88 mm Hg, respectively), all with P values 35 kg/m 2 , frequently resulting in diabetes remission and improvement in associated obesity-related conditions
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Combining this medicine with other vasodilators can together improve male sex functionality by managing different aspects of the underlying ways, blood flow regulation, and tissue recovery
He went and got his Retatrutide from peptide sciences labs tested and it turned out to be underdosed tirzepatide
Andrew: For those that are listening to this and they may recall, I did an episode of this podcast with Dr
It does not contain amino acids and is not produced by peptide-bond chemistry